U.S. Markets closed

Top Stock Picks for Week of July 8, 2019

Panel Of Zacks Experts

Dollar General Corporation DG, is a discount retailer in the United States.  Shares of Dollar General have risen and outpaced the industry in the past six months. The stock may scale new highs with solid prospects, brand recognition and strategic endeavors likely to act as propellants. Better pricing, private label offering, inventory management, and merchandise and operational initiatives should drive sales. For first-quarter fiscal 2019, both sales and earnings per share beat the Zacks Consensus Estimate. Dollar General reported better-than-expected first-quarter fiscal 2019 results, wherein both the top and bottom line revenue grew year over year. Also, the company witnessed sturdy same-store sales performance. Looking ahead, the company retained fiscal 2019 view.

Construction Partners Inc. ROAD, is an infrastructure and road construction company. It went public fairly recently and is one of the only publicly traded companies that specializes in road construction. The company currently has a Zacks Rank of #1 (Strong Buy), as well as a Value grade of A. Our model also underscores that ROAD has a P/CF ratio of 11.36. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 13.94. This is only one of the key metrics included in Construction Partner's strong Value grade, but it helps show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, ROAD looks like an impressive value stock at the moment.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dollar General Corporation (DG) : Free Stock Analysis Report
Construction Partners, Inc. (ROAD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research